Moody National Bank Trust Division’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-20,849
Closed -$625K 523
2026
Q1
$625K Hold
20,849
0.06% 305
2025
Q4
$682K Hold
20,849
0.07% 290
2025
Q3
$722K Hold
20,849
0.06% 303
2025
Q2
$584K Sell
20,849
-5,291
-20% -$142K 0.05% 325
2025
Q1
$657K Hold
26,140
0.07% 304
2024
Q4
$719K Hold
26,140
0.08% 295
2024
Q3
$753K Buy
26,140
+3,622
+16% +$98.6K 0.08% 280
2024
Q2
$558K Hold
22,518
0.04% 299
2024
Q1
$725K Hold
22,518
0.06% 250
2023
Q4
$915K Buy
22,518
+3,679
+20% +$135K 0.07% 215
2023
Q3
$651K Buy
18,839
+10,663
+130% +$415K 0.04% 318
2023
Q2
$332K Buy
8,176
+2,019
+33% +$82.3K 0.02% 481
2023
Q1
$238K Buy
+6,157
New +$253K 0.02% 556
2021
Q3
Sell
-3,500
Closed -$241K 418
2021
Q2
$241K Sell
3,500
-288
-8% -$22K ﹤0.01% 379
2021
Q1
$292K Hold
3,788
0.01% 356
2020
Q4
$375K Buy
3,788
+69
+2% +$8.44K 0.01% 319
2020
Q3
$528K Hold
3,719
0.02% 281
2020
Q2
$734K Buy
3,719
+8
+0.2% +$1.66K 0.02% 259
2020
Q1
$727K Sell
3,711
-37
-1% -$7.96K 0.03% 241
2019
Q4
$775K Hold
3,748
0.02% 247
2019
Q3
$572K Buy
3,748
+248
+7% +$40.6K 0.02% 268
2019
Q2
$451K Hold
3,500
0.01% 283
2019
Q1
$412K Hold
3,500
0.01% 293
2018
Q4
$321K Hold
3,500
0.01% 299
2018
Q3
$394K Buy
+3,500
New +$370K 0.01% 288

Other funds holding LKFT

Moody National Bank Trust Division's LKFT Position: Q2 2026 in Review

Moody National Bank Trust Division sold out of Lakefront Biotherapeutics American Depositary Shares (LKFT) in Q2 2026, closing a stake of 20,849 shares — an estimated $625K sold.

Moody National Bank Trust Division first reported a position in LKFT in Q3 2018 and held it in 25 quarters. The position peaked at $915K in Q4 2023. 24 funds tracked by Wall St. Rank hold LKFT as of Q2 2026.

  • Moody National Bank Trust Division reported no remaining Lakefront Biotherapeutics American Depositary Shares position as of Q2 2026 after selling out during the quarter.
  • Moody National Bank Trust Division sold 20,849 Lakefront Biotherapeutics American Depositary Shares shares in Q2 2026, an estimated $625K.
  • Moody National Bank Trust Division first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q3 2018 and held it in 25 quarters.
  • Moody National Bank Trust Division's Lakefront Biotherapeutics American Depositary Shares position peaked at $915K in Q4 2023.
  • 24 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q2 2026.

Based on Moody National Bank Trust Division's 13F filing for Q2 2026, filed 7 Jul 2026.